In addition, NAFLD rodents supplemented with probiotics were presented with reduced MCP-1, a chemokine with pivotal roles in the development of inflammatory responses and crucial for immune cell recruitment to inflammation sites (70), both of which contribute to the progression of hepatic inflammation and fibrosis (71). Here, CCL2 is linked to metabolic dysfunction-associated steatotic liver disease.